Table 3.
Interview respondent characteristics, total sample
| Country | Global | Total | ||||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Data | ||||||
| No. of interviews completed | 177 | – | 18 | – | 194 | – |
| No. of interviews included in analysis | 177 | – | 17a | 94.4 | 193 | 99.5 |
| Level | ||||||
| Global actors | 0 | 0 | 17 | 100.0 | 17 | 8.8 |
| National actors | 84 | 47.5 | 0 | 0 | 84 | 43.3 |
| Subnational actors | 71 | 40.1 | 0 | 0 | 71 | 36.6 |
| Frontline health workers | 22 | 12.4 | 0 | 0 | 22 | 11.3 |
| Affiliation | ||||||
| Academic organization | 4 | 2.3 | 1 | 5.9 | 5 | 2.5 |
| Consulting firm | 1 | 0.6 | 0 | 0 | 1 | 0.5 |
| Government | 96 | 54.2 | 0 | 0 | 96 | 49.5 |
| GPEI partners | 45 | 25.4 | 14 | 82.3 | 59 | 30.4 |
| Implementing organization | 21 | 11.9 | 2 | 11.8 | 23 | 11.9 |
| Other (e.g. clinical) | 10 | 5.6 | 0 | 0 | 10 | 5.2 |
| Gender | ||||||
| Female | 46 | 26.0 | 4 | 23.5 | 50 | 25.8 |
| Male | 131 | 74.0 | 13 | 76.5 | 144 | 74.2 |
One respondent’s interview was inaudible and could not be reviewed for analysis.